Supplementary Table S1 from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity <i>in vitro</i> and <i>in vivo</i>

Christian A. Hassig,Kent T. Symons, Xin Guo, Phan-Manh Nguyen,Tami Annable, Paul L. Wash,Joseph E. Payne,David A. Jenkins, Céline Bonnefous, Carol Trotter,Yan Wang, John V. Anzola, Elena L. Milkova,Timothy Z. Hoffman,Sara J. Dozier,Brandon M. Wiley,Alan Saven, James W. Malecha,Robert L. Davis, Jerry Muhammad,Andrew K. Shiau, Stewart A. Noble,Tadimeti S. Rao,Nicholas D. Smith,Jeffrey H. Hager

crossref（2023）

引用 0|浏览3

暂无评分

摘要

Supplementary Table S1 from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Table S1 from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt;

Supplementary Table S1 from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity <i>in vitro</i> and <i>in vivo</i>